Package 51655-044-52

Brand: amlodipine besylate

Generic: amlodipine besylate
NDC Package

Package Facts

Identity

Package NDC 51655-044-52
Digits Only 5165504452
Product NDC 51655-044
Description

30 TABLET in 1 BOTTLE, PLASTIC (51655-044-52)

Marketing

Marketing Status
Marketed Since 2023-11-30
Brand amlodipine besylate
Generic amlodipine besylate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "499b91fb-79d3-b1af-e063-6294a90a3344", "openfda": {"unii": ["864V2Q084H"], "rxcui": ["197361"], "spl_set_id": ["0c5784b9-5542-144f-e063-6394a90a7ebc"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (51655-044-52)", "package_ndc": "51655-044-52", "marketing_start_date": "20231130"}], "brand_name": "AMLODIPINE BESYLATE", "product_id": "51655-044_499b91fb-79d3-b1af-e063-6294a90a3344", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "51655-044", "generic_name": "AMLODIPINE BESYLATE", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AMLODIPINE BESYLATE", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}], "application_number": "ANDA077073", "marketing_category": "ANDA", "marketing_start_date": "20231130", "listing_expiration_date": "20271231"}